While reperfusion therapy using tPA is effective for occlusive stroke, the short therapeutic window and risk of hemorrhage limit the benefit of tPA in patients with ischemic stroke, highlighting an urgent yet unmet need for a combination treatment that would reduce tPA-associated hemorrhagic transformation to extend its efficacy and therapeutic window. This evidence concerns the gene PLAT and ischemic stroke.